U.S. markets open in 8 hours 7 minutes
  • S&P Futures

    4,261.25
    +5.25 (+0.12%)
     
  • Dow Futures

    34,208.00
    +126.00 (+0.37%)
     
  • Nasdaq Futures

    14,361.50
    +7.25 (+0.05%)
     
  • Russell 2000 Futures

    2,334.70
    +3.50 (+0.15%)
     
  • Crude Oil

    73.33
    +0.03 (+0.04%)
     
  • Gold

    1,775.60
    -1.10 (-0.06%)
     
  • Silver

    26.07
    +0.02 (+0.06%)
     
  • EUR/USD

    1.1939
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    15.97
    -0.35 (-2.14%)
     
  • GBP/USD

    1.3922
    +0.0001 (+0.01%)
     
  • USD/JPY

    110.8560
    +0.0210 (+0.02%)
     
  • BTC-USD

    34,665.03
    +1,944.15 (+5.94%)
     
  • CMC Crypto 200

    833.35
    +46.74 (+5.94%)
     
  • FTSE 100

    7,109.97
    +35.91 (+0.51%)
     
  • Nikkei 225

    29,081.03
    +205.80 (+0.71%)
     

What Does Syneos Health, Inc.'s (NASDAQ:SYNH) Share Price Indicate?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Syneos Health, Inc. (NASDAQ:SYNH), might not be a large cap stock, but it saw a decent share price growth in the teens level on the NASDAQGS over the last few months. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, what if the stock is still a bargain? Let’s take a look at Syneos Health’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Syneos Health

Is Syneos Health still cheap?

Great news for investors – Syneos Health is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is $101.67, but it is currently trading at US$75.53 on the share market, meaning that there is still an opportunity to buy now. Although, there may be another chance to buy again in the future. This is because Syneos Health’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of Syneos Health look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Syneos Health's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? Since SYNH is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on SYNH for a while, now might be the time to make a leap. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy SYNH. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.

In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To help with this, we've discovered 2 warning signs (1 is a bit concerning!) that you ought to be aware of before buying any shares in Syneos Health.

If you are no longer interested in Syneos Health, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.